 | • レポートコード：B-GIR09D3986 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、がん治療用遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入等、用途別セグメントは、病院、クリニック、その他等に区分しました。がん治療用遺伝子治療の世界市場概観、企業動向、企業別がん治療用遺伝子治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・がん治療用遺伝子治療の市場概観 ・がん治療用遺伝子治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・がん治療用遺伝子治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・がん治療用遺伝子治療の世界市場規模 ・がん治療用遺伝子治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・がん治療用遺伝子治療のアメリカ市場規模推移 ・がん治療用遺伝子治療のカナダ市場規模推移 ・がん治療用遺伝子治療のメキシコ市場規模推移 ・がん治療用遺伝子治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・がん治療用遺伝子治療のドイツ市場規模推移 ・がん治療用遺伝子治療のイギリス市場規模推移 ・がん治療用遺伝子治療のロシア市場規模推移 ・がん治療用遺伝子治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・がん治療用遺伝子治療の日本市場規模推移 ・がん治療用遺伝子治療の中国市場規模推移 ・がん治療用遺伝子治療の韓国市場規模推移 ・がん治療用遺伝子治療のインド市場規模推移 ・がん治療用遺伝子治療の東南アジア市場規模推移 ・がん治療用遺伝子治療の南米市場分析（ブラジル、アルゼンチン等） ・がん治療用遺伝子治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・がん治療用遺伝子治療の種類別分析/販売量、売上、市場シェア（遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入） ・がん治療用遺伝子治療の用途別分析/市場規模（病院、クリニック、その他） ・がん治療用遺伝子治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・がん治療用遺伝子治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Gene therapy is the therapeutic delivery of nucleic acid into a patient’s cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
Scope of the Report:
In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.
The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.
ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.
The global Gene Therapies for Cancer Treatment market is valued at 1940 million USD in 2018 and is expected to reach 25300 million USD by the end of 2024, growing at a CAGR of 67.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapies for Cancer Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Gene Therapies for Cancer Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gene Therapies for Cancer Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Market Segment by Applications, can be divided into
Hospital
Clinic
Other
Table of Contents
1 Gene Therapies for Cancer Treatment Market Overview
1.1 Product Overview and Scope of Gene Therapies for Cancer Treatment
1.2 Classification of Gene Therapies for Cancer Treatment by Types
1.2.1 Global Gene Therapies for Cancer Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Types in 2018
1.2.3 Gene Induced Immunotherapy
1.2.4 Oncolytic Virotherapy
1.2.5 Gene Transfer
1.3 Global Gene Therapies for Cancer Treatment Market by Application
1.3.1 Global Gene Therapies for Cancer Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gene Therapies for Cancer Treatment Market by Regions
1.4.1 Global Gene Therapies for Cancer Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Gene Therapies for Cancer Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Gene Therapies for Cancer Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Kite Pharma
2.2.1 Business Overview
2.2.2 Gene Therapies for Cancer Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kite Pharma Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Amgen
2.3.1 Business Overview
2.3.2 Gene Therapies for Cancer Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Amgen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Shanghai Sunway
2.4.1 Business Overview
2.4.2 Gene Therapies for Cancer Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Shanghai Sunway Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sibiono
2.5.1 Business Overview
2.5.2 Gene Therapies for Cancer Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sibiono Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gene Therapies for Cancer Treatment Market Competition, by Players
3.1 Global Gene Therapies for Cancer Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Therapies for Cancer Treatment Players Market Share
3.2.2 Top 10 Gene Therapies for Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Global Gene Therapies for Cancer Treatment Market Size by Regions
4.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Regions
4.2 North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
5 North America Gene Therapies for Cancer Treatment Revenue by Countries
5.1 North America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
5.2 USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
6 Europe Gene Therapies for Cancer Treatment Revenue by Countries
6.1 Europe Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
6.2 Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
6.4 France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
7.2 China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
7.5 India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
8 South America Gene Therapies for Cancer Treatment Revenue by Countries
8.1 South America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
8.2 Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Gene Therapies for Cancer Treatment by Countries
9.1 Middle East and Africa Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
10 Global Gene Therapies for Cancer Treatment Market Segment by Type
10.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Gene Induced Immunotherapy Revenue Growth Rate (2014-2024)
10.4 Oncolytic Virotherapy Revenue Growth Rate (2014-2024)
10.5 Gene Transfer Revenue Growth Rate (2014-2024)
11 Global Gene Therapies for Cancer Treatment Market Segment by Application
11.1 Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2014-2019)
11.2 Gene Therapies for Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)
12.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)
12.2 Global Gene Therapies for Cancer Treatment Market Forecast by Regions (2019-2024)
12.3 North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
12.6 South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Gene Therapies for Cancer Treatment Picture
Table Product Specifications of Gene Therapies for Cancer Treatment
Table Global Gene Therapies for Cancer Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Gene Therapies for Cancer Treatment Revenue Market Share by Types in 2018
Figure Gene Induced Immunotherapy Picture
Figure Oncolytic Virotherapy Picture
Figure Gene Transfer Picture
Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Application (2014-2024)
Figure Gene Therapies for Cancer Treatment Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Market Gene Therapies for Cancer Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gene Therapies for Cancer Treatment Type and Applications
Table Novartis Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Kite Pharma Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Gene Therapies for Cancer Treatment Type and Applications
Table Kite Pharma Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Gene Therapies for Cancer Treatment Type and Applications
Table Amgen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Sunway Basic Information, Manufacturing Base and Competitors
Table Shanghai Sunway Gene Therapies for Cancer Treatment Type and Applications
Table Shanghai Sunway Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sibiono Basic Information, Manufacturing Base and Competitors
Table Sibiono Gene Therapies for Cancer Treatment Type and Applications
Table Sibiono Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue Share by Players (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Share by Players in 2017
Figure Global Gene Therapies for Cancer Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2018
Figure Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions in 2018
Figure North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Table North America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
Table North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018
Figure USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Table Europe Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018
Figure Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018
Figure China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Table South America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
Table South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018
Figure Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue Share by Type (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Share by Type (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Share by Type in 2019
Table Global Gene Therapies for Cancer Treatment Revenue Forecast by Type (2019-2024)
Figure Global Gene Therapies for Cancer Treatment Market Share Forecast by Type (2019-2024)
Figure Global Gene Induced Immunotherapy Revenue Growth Rate (2014-2019)
Figure Global Oncolytic Virotherapy Revenue Growth Rate (2014-2019)
Figure Global Gene Transfer Revenue Growth Rate (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue by Application (2014-2019)
Table Global Gene Therapies for Cancer Treatment Revenue Share by Application (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Share by Application (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue Share by Application in 2019
Table Global Gene Therapies for Cancer Treatment Revenue Forecast by Application (2019-2024)
Figure Global Gene Therapies for Cancer Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Gene Therapies for Cancer Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Gene Therapies for Cancer Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
Figure Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
Figure South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…- 世界の遺伝子発現プロファイリング市場予測（～2024年）：企業別、地域別、種類・用途別 Gene expression analysis is most simply described as the study of the way genes are transcribed to synthesize functional gene products. Scope of the Report: The global Gene Expression Profiling market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, gro…
- 世界の緑内障手術療法市場予測（～2024年）：企業別、地域別、種類・用途別 Surgery involves either laser treatment or making a cut in the eye to reduce the intraocular pressure. The type of surgery your doctor recommends will depend on the type and severity of your glaucoma and the general health of your eye. Scope of the Report: The global Glaucoma Surgery Therapies marke…
- 世界の遺伝子合成サービス市場予測（～2024年）：企業別、地域別、種類・用途別 Description Scope of the Report: The global Gene Synthesis Service market is valued at 258.4 million USD in 2018 and is expected to reach 492.1 million USD by the end of 2024, growing at a CAGR of 17.5% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, esp…
- 世界の遺伝子編集技術市場予測（～2024年）：企業別、地域別、種類・用途別 Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Scope of the Report: The global Gene Editing Technologies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024,…